The Ministry of Industry, the King Abdullah International Center for Medical Research (KIMAR), and the Pfizer Scientific Foundation have agreed to build the foundations for the manufacture of viral and genetic vaccines in the Kingdom.
This came on the sidelines of the “Riyadh International Summit for Medical Technology “2021”, in the presence of a group of health sector experts in the world through a video broadcast, organized by the King Abdullah International Center for Medical Research at the Ministry of National Guard Health Affairs at the Ritz-Carlton Hotel.
Tawfiq Al-Rabiah, Minister of Health, said that the Riyadh International Summit for Medical Technology comes at a time when it has become necessary to discuss the areas of developing this technology because of its direct and close relationship to human health, noting that the global market value of biotechnology is expected to reach nearly more than $700 billion by 2025, and global sales of biotechnology drugs are expected to reach nearly $315 billion this year.
He added: And through the integrated vision of our country and the achievement of Vision 2030, the leadership sought to have a national strategy for biomedical technology, one of the most prominent branches of this strategy, to support and motivate it for the future and health of man.
These were the details of the news Manufacture of Pfizer Vaccines in Saudi Arabia for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.
It is also worth noting that the original news has been published and is available at saudi24news and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.
